M. Castillo Orive

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries

José María Cepeda, Nicolás Manito, Alejandro Recio‐Mayoral, Iñaki Lekuona et autres

Background: The objective of the study was to analyze and compare the effectiveness and safety of rivaroxaban in patients with atrial fibrillation (AF) and heart failure (HF). Methods: The clinical profile and outcomes of the FARAONIC study were indirectly compared with those …

es (code pays fourni par la source)

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

Guillaume Roger, Grégory Ducrocq, Jules Mesnier, Neila Sayah et autres

BACKGROUND AND AIMS: It has been reported that patients without standard modifiable cardiovascular (CV) risk factors (SMuRFs-diabetes, dyslipidaemia, hypertension, and smoking) presenting with first myocardial infarction (MI), especially women, have a higher in-hospital mortality than patients with risk factors, and possibly a …

fr, it, gb, ca, pl (code pays fourni par la source)

Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban

Nicolás Manito, J.M. Cepeda-Rodrigo, Núria Farré, M. Castillo Orive et autres

BACKGROUND: Patients with atrial fibrillation (AF) and heart failure (HF) have a high risk of thromboembolism and other outcomes and anticoagulation is recommended. HYPOTHESIS: This study was aimed to explore the risk factors associated with HF worsening in patients with AF and …

es (code pays fourni par la source)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne, Rajashekhar Durgaprasad et autres

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes …

in, pk, gb, us (code pays fourni par la source)

Protocolo diagnóstico y diagnóstico diferencial de la pericarditis constrictiva

José Luis Moya Mur, M. Castillo Orive, Ana García Martín, Eduardo Casas Rojo

es (code pays fourni par la source)

Pericarditis constrictiva

José Luis Moya Mur, Eduardo Casas Rojo, Ana García Martín, M. Castillo Orive

es (code pays fourni par la source)

Poster session: Aortic stenosis

I. Jovanović, M. Tesic, Ivana Paunović, Milan Dobrić et autres

Background: Patients with left main coronary artery (LMCA) stenosis are considered to be vulnerable population that requires reliable assessment of functional significance of lesions observed on coronary angiography.The aim of this study was to determine the prognostic value of noninvasively measured coronary …

rs, se, gr, it, gb (code pays fourni par la source)

Bradiarritmias. Trastornos de la conducción auriculoventricular

M. Castillo Orive, C. Moro Serrano

es (code pays fourni par la source)

Protocolo diagn?stico de las taquicardias con QRS ancho

M. Castillo Orive, C. Moro Serrano

es (code pays fourni par la source)

Protocolo diagn?stico de las taquicardias con intervalo RR irregular

A. Hernndez Madrid, M. Castillo Orive, C. Moro Serrano

es (code pays fourni par la source)

Protocolo diagn?stico de las taquicardias regulares de QRS estrecho

M. Castillo Orive, C. Moro Serrano

es (code pays fourni par la source)